"Apolipoprotein L1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ApoL protein highly expressed by the liver. It has anti-trypanosomal activity through its ability to permeabilize TRYPANOSOMA membranes. Mutations in the APOL1 gene are associated with type 4 FOCAL SEGMENTAL GLOMERULOSCLEROSIS .
| Descriptor ID |
D000075944
|
| MeSH Number(s) |
D10.532.091.750.500 D12.776.070.400.750.500 D12.776.521.120.750.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Apolipoprotein L1".
Below are MeSH descriptors whose meaning is more specific than "Apolipoprotein L1".
This graph shows the total number of publications written about "Apolipoprotein L1" by people in this website by year, and whether "Apolipoprotein L1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 1 | 1 | 2 |
| 2022 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Apolipoprotein L1" by people in Profiles.
-
Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 Genotypes. Clin J Am Soc Nephrol. 2023 03 01; 18(3):344-355.
-
Apolipoprotein L1 Opinions of African American Living Kidney Donors, Kidney Transplant Patients, and Nonpatients. J Surg Res. 2022 09; 277:116-124.
-
Opinions of African American adults about the use of apolipoprotein L1 (ApoL1) genetic testing in living kidney donation and transplantation. Am J Transplant. 2021 03; 21(3):1197-1205.
-
The kidney evaluation of living kidney donor candidates: US practices in 2017. Am J Transplant. 2020 12; 20(12):3379-3389.
-
New approaches to genetic predisposition for hemorrhagic stroke in sickle cell disease. J Clin Hypertens (Greenwich). 2018 06; 20(6):1078-1079.
-
APOL1, CDKN2A/CDKN2B, and HDAC9 polymorphisms and small vessel ischemic stroke. Acta Neurol Scand. 2018 Jan; 137(1):133-141.
-
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol. 2014 Feb; 66(2):390-6.
-
Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis. Genes Immun. 2012 Apr; 13(3):232-8.